Functional recovery after delayed treatment of ischemic stroke with melanocortins is associated with overexpression of the activity-dependent gene Zif268.
Melanocortin peptides afford strong neuroprotection and improve functional recovery in experimental ischemic stroke; they also have established neurotrophic actions. The expression of the immediate early gene Zif268 is dependent on synaptic activity and is involved in injury repair and memory formation. Here, we investigated the role of Zif268 in learning and memory recovery after delayed treatment of ischemic stroke with the melanocortin analog [Nle(4), D-Phe(7)]alpha-MSH (NDP-alpha-MSH). A 10-min period of global cerebral ischemia was induced by occluding both common carotid arteries in gerbils. Treatment with a nanomolar dose of NDP-alpha-MSH (every 12h for 11 days) was performed starting 3h or 9h after stroke induction; where indicated, gerbils were pretreated with the melanocortin MC(4) receptor antagonist HS024. Animals were subjected to the Morris water-maze test (four sessions from 4 to 50 days after the ischemic episode). Fifty days after stroke, histological damage and Zif268 expression were investigated in the hippocampus. Treatment with NDP-alpha-MSH significantly reduced hippocampal damage, including neuronal death, and improved learning and memory recovery. This protective effect was long-lasting (50 days, at least) and associated with Zif268 overexpression, with both schedules of NDP-alpha-MSH treatment. Pharmacological blockade of MC(4) receptors prevented these effects. Our data indicate that MC(4) receptor-mediated actions of melanocortins could trigger repair mechanisms able to improve neuronal functionality and synaptic plasticity, and to promote long-lasting functional recovery from ischemic stroke with Zif268 gene involvement.
Department of Biomedical Sciences, Section of Pharmacology, University of Modena and Reggio Emilia, Via G. Campi 287, Modena, Italy.
Daniela
D
Giuliani
Alessandra
A
Ottani
Letteria
L
Minutoli
Vincenzo Di
VD
Stefano
Maria
M
Galantucci
Alessandra
A
Bitto
Davide
D
Zaffe
Domenica
D
Altavilla
Annibale R
AR
Botticelli
Francesco
F
Squadrito
Salvatore
S
Guarini
D000818:Animals; D015153:Blotting, Western; D051766:Early Growth Response Protein 1 / Q000096:biosynthesis* / Q000235:genetics; D005849:Gerbillinae; D002546:Ischemic Attack, Transient / Q000150:complications*; D007858:Learning / Q000502:physiology; D008297:Male; D018782:Maze Learning / Q000187:drug effects; D053486:Melanocortins / Q000627:therapeutic use*; D008568:Memory / Q000502:physiology; D020127:Recovery of Function; D020521:Stroke / Q000188:drug therapy* / Q000209:etiology*; D000521:alpha-MSH / Q000031:analogs & derivatives / Q000494:pharmacology
D051766:Early Growth Response Protein 1; D053486:Melanocortins; D000521:alpha-MSH; C027756:MSH, 4-Nle-7-Phe-alpha-